Natural History of Patients Diagnosed with Cardiac Sarcoidosis at Left Ventricular Assist Device Implantation or

Tyler J Schmidt1, Andrew N Rosenbaum2, Nikhil Kolluri1

  • 1From the Department of Internal Medicine.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|April 26, 2021
PubMed

Insights

Cardiac sarcoidosis (CS) diagnosed during heart transplantation or LVAD implantation often presents as severe heart failure. Outcomes for these patients are comparable to those without CS.

Area of Science:

  • Cardiology
  • Pathology
  • Immunology

Background:

  • Cardiac sarcoidosis (CS) diagnosis often occurs late, particularly when identified incidentally during advanced heart failure therapy evaluations.
  • The natural history of CS diagnosed pathologically at left ventricular assist device (LVAD) implantation or cardiac transplantation is not well-documented.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of patients with CS incidentally diagnosed via pathological examination of the apical core or explanted heart.
  • To compare these outcomes with patients diagnosed with CS prior to advanced heart failure therapies.

Main Methods:

  • Retrospective review of 232 patients meeting CS criteria.
  • Pathological confirmation of CS in 54 patients, with 10 diagnosed incidentally during LVAD implantation or heart transplantation.
  • Comparison of clinical data and outcomes between the 10 incidentally diagnosed patients and 10 patients with pre-existing CS.

Main Results:

  • The 10 incidentally diagnosed patients often presented with severe dilated cardiomyopathy (mean ejection fraction 23%).
  • Half of the incidentally diagnosed patients had no prior diagnosis of sarcoidosis.
  • No significant survival difference was observed between incidentally diagnosed CS patients and those with known CS or general advanced heart failure cohorts.

Conclusions:

  • Incidental pathological diagnosis of CS during LVAD or transplant evaluation can reveal severe cardiomyopathy as the initial presentation.
  • Patients with CS diagnosed during advanced heart failure therapies may have outcomes similar to non-CS patients, suggesting effective management strategies.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
102
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
117
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
118
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
162